Aligos Therapeutics, Inc 10-K for FY2023
Aligos Therapeutics, Inc. (ALGS)
10-K
2024-03-12
For: 2023-12-31
View Original
Added on
April 11, 2026
About this 10-K
Aligos Therapeutics, Inc filed this 10-K on March 12, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $6.19M
- Net loss
- $87.68M
- compared with a net loss of $96.05M a year earlier
- Diluted EPS
- -$1.36
- compared with -$2.25 a year earlier